Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
2765PDF: 1800HTML: 3663Pellagatti Fig 1: 210Pellagatti Fig. 2: 207 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2932PDF: 888HTML: 1746 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1981PDF: 1120HTML: 615 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3746PDF: 1474HTML: 482Figures . Eliassian: 220 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2572PDF: 797HTML: 5208 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1362HTML: 389PDF: 814 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2172PDF: 1475HTML: 263 -
Pseudo-differentiation syndrome
1339PDF: 656HTML: 10846Figure 1: peripheral blood showing myeloblasts with auer rods: 117Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 102Figure 3: CXR showing pulmonary infiltartes with consolidation: 136Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 109Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 118 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2100PDF: 1683HTML: 374 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3865PDF: 751HTML: 1847 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4794PDF: 1793HTML: 2129 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1959PDF: 743HTML: 694 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3752PDF: 1649HTML: 11571Figures Haase: 195 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3670PDF: 1433HTML: 181 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1775PDF: 964HTML: 140 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1767PDF: 938HTML: 1107Untitled: 151Untitled: 170Untitled: 157Untitled: 158 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4080PDF: 3367HTML: 201 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1751PDF: 873HTML: 373Fig1: 230Fig.2: 250Fig. 3: 179Fig. 5: 195Fig. 4: 222 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2789PDF: 1004HTML: 5518 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1216PDF: 582HTML: 2858ATRA induced Reactive Hemophagocytosis: A Case Report: 196 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1797PDF: 800HTML: 10230Figures 1,2,3: 172 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1402PDF: 897Suppl. Files: 452HTML: 233 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1016PDF: 611HTML: 73 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7415PDF: 2414HTML: 1726Table 1.: 205Table 2.: 216Table 3.: 198Table 4.: 198 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1235PDF: 858HTML: 1115Coverletter: 191 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3499PDF: 877HTML: 1650figure 1: 163Untitled: 187 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13252PDF: 962HTML: 7288 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1253PDF: 527HTML: 23037 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2382PDF: 910HTML: 483 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1745PDF: 528HTML: 16967Figure 4: 166Figure 3: 139Figure 2: 144Figure 1: 175 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1326PDF: 821HTML: 127 -
-
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1029PDF: 1151Suppl. Files: 569HTML: 83 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2279PDF: 1320HTML: 17076Bassan Fig.1: 140Bassan Fig.2: 153Bassan Fig.4: 139Fig.3: 182







